No 2025:4: Examining Publicly Available Price Lists – The Case of Hospital Drug Administration Costs in Sweden
Bardh Manxhuka, Magnus Värendh and Jonas Hjelmgren
No 2025:3: Vad får framtidens läkemedel kosta och vad kan de ge i besparingar?
Ulf Persson
No 2025:2: Comparator Report on Cancer in Europe 2025 – Disease Burden, Costs and Access to Medicines and Molecular Diagnostics
Andrea Manzano, Christer Svedman, Thomas Hofmarcher and Nils Wilking
No 2025:1: An analysis of behaviour, health, and GDP during the Covid-19 pandemic in Europe
Ulf Persson, Pierre-Yves Geoffard, Jörgen Möller and Gunnar Brådvik
Questions (including download problems) about the papers in this series should be directed to Annette Persson Dietmann ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2025-05-07 12:13:45.